Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can cancer treatment also kick the habit? new study tests combined approach

NCT ID NCT02540174

Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether adding a structured addiction treatment program to standard cancer care helps patients with head and neck or lung cancer quit smoking and reduce alcohol use. 133 patients were randomly assigned to either the integrated program or usual care. The main goal was to see how many patients were tobacco-free at 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
integrated addiction treatment program
What this could lead to
If it works, this could show that combining addiction treatment with cancer care helps more patients quit smoking and drinking, potentially improving their overall health and cancer outcomes.
What could go wrong
This is a completed study with 133 participants, so results are available but may not apply to all patients. The program is intensive and may not be feasible in all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

133 people

The number who actually took part.

Started

May 2015

Finished

Dec 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a first upper aerodigestive tract cancer or a lung cancer * Initial cancer treatment * Aged ≥ 18 and ≤65 years * Living within a radius of 20 km from the CHRU de Lille/Oscar Lambret Center * Patient with tobacco addiction: regular smoker = at least 7 cigarettes /week or 1 cigarette/day or short-term ex-smoker = regular smoker who has stopped smoking for less than 1 year from the inclusion date * Performance status (ECOG/WHO) ≤ 2 * Registered with a social security system * Informed and signed consent collected before initiation of any study procedures Exclusion Criteria: * Previous lung cancer or upper aerodigestive tract cancer * Previous other cancer \< 5 years, evoluting or treated at the inclusion (except uterine cervical carcinoma, basal cell or squamous cell skin carcinoma ) * Mesothelioma and esophageal cancer * Occasional smoker (less than 7 cigarettes/week or less than 1 cigarette/day) * Long-term ex-smokers who have stopped smoking for more than 1 year from the inclusion date * Impossibility to comply with the study procedures due to geographic, social or mental reasons * Patient under guardianship or tutorship * Pregnant or breastfeeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms lung cancer lung neoplasm Tobacco Use upper aerodigestive tract neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer Upper aerodigestive tract neoplasms

Contacts and locations

Locations

  • CHRU of Lille : Albert Calmette Hospital

    Lille, 59037, France

  • CHRU of Lille: Huriez Hospital

    Lille, 59037, France

  • Oscar Lambret Center

    Lille, 59020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.